✦ LIBER ✦

Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination

✍ Scribed by Jesus Esquivel; Dominique Elias; Dario Baratti; Shigeki Kusamura; Marcello Deraco

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 86 KB
Volume: 98
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.21053

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Consensus statement on the loco-regional

Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei)

✍ Brendan Moran; Dario Baratti; Tristan D. Yan; Shigeki Kusamura; Marcello Deraco 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Treatment of patients with disseminated

Treatment of patients with disseminated colorectal cancer with recombinant human alpha2-interferon. Studies on the immune system

✍ Stefan Einhorn; Jerzy Wasserman; Göran Lundell; Henric Blomgren; Björn Cedermark 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 French ⚖ 606 KB

The influence of recombinant human alpha 2-interferon (alpha 2-IFN) therapy on various aspects of the immune system was studied in 18 patients with disseminated colorectal cancer. The IFN was given as continuous (20 X 10(6) units/m2 three times weekly) or intermittent (50 X 10(6) units/m2 daily for

Lymphatic dissemination of hepatic metas

Lymphatic dissemination of hepatic metastases. Implications for the follow-up and treatment of patients with colorectal cancer

✍ David A. August; Paul H. Sugarbaker; Philip D. Schneider 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 607 KB

The impact of detection and treatment on

The impact of detection and treatment on lifetime medical costs for patients with precancerous polyps and colorectal cancer

✍ David H. Howard; Florence K. Tangka; Laura C. Seeff; Lisa C. Richardson; Donatus 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

## Abstract Understanding the costs associated with early detection of disease is important for determining the fiscal implications of government‐funded screening programs. We estimate the lifetime medical costs for patients with screen‐detected versus undetected polyps and early‐stage colorectal c